PON2 and melanoma: Since PON2 overexpression is markedly enhanced in advanced lesions, which are known to be unsuccessfully treated with chemotherapy due to melanoma cell resistance, it was conceivable to hypothesize a potential enzyme contribution to molecular processes related to melanoma cell resistance to chemotherapeutic compounds.